a month ago

AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger

The Guardian
a month ago

AstraZeneca and Bristol Myers Squibb discuss $400bn tie-up

FT
AstraZeneca Bristol Myers Squibb

←Top Latest Headlines